Edwards Lifesciences Corp (NYSE: EW) has a price-to-earnings ratio that is above its average at 10.23x. The stock has a 36-month beta value of 1.13. Opinions on the stock are mixed, with 8 analysts rating it as a “buy,” 5 as “overweight,” 19 as “hold,” and 0 as “sell.”
The public float for EW is 579.77M, and at present, short sellers hold a 1.18% of that float. On December 10, 2024, the average trading volume of EW was 5.87M shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
EW) stock’s latest price update
Edwards Lifesciences Corp (NYSE: EW)’s stock price has dropped by -0.88 in relation to previous closing price of 71.53. Nevertheless, the company has seen a gain of 0.52% in its stock price over the last five trading days. accesswire.com reported 2024-12-09 that NEW YORK, NY / ACCESSWIRE / December 9, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=115616&wire=1 or contact Joseph E. Levi, Esq.
EW’s Market Performance
Edwards Lifesciences Corp (EW) has seen a 0.52% rise in stock performance for the week, with a 7.69% gain in the past month and a 5.60% surge in the past quarter. The volatility ratio for the week is 2.97%, and the volatility levels for the past 30 days are at 2.62% for EW. The simple moving average for the past 20 days is 1.32% for EW’s stock, with a -10.12% simple moving average for the past 200 days.
Analysts’ Opinion of EW
Many brokerage firms have already submitted their reports for EW stocks, with Morgan Stanley repeating the rating for EW by listing it as a “Equal-Weight.” The predicted price for EW in the upcoming period, according to Morgan Stanley is $70 based on the research report published on October 11, 2024 of the current year 2024.
Jefferies, on the other hand, stated in their research note that they expect to see EW reach a price target of $70, previously predicting the price at $85. The rating they have provided for EW stocks is “Hold” according to the report published on September 18th, 2024.
EW Trading at 3.31% from the 50-Day Moving Average
After a stumble in the market that brought EW to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -26.24% of loss for the given period.
Volatility was left at 2.62%, however, over the last 30 days, the volatility rate increased by 2.97%, as shares surge +7.05% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +6.49% upper at present.
During the last 5 trading sessions, EW rose by +0.52%, which changed the moving average for the period of 200-days by -19.19% in comparison to the 20-day moving average, which settled at $69.97. In addition, Edwards Lifesciences Corp saw -7.02% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at EW starting from Ullem Scott B., who sale 11,250 shares at the price of $71.68 back on Dec 09 ’24. After this action, Ullem Scott B. now owns 30,561 shares of Edwards Lifesciences Corp, valued at $806,406 using the latest closing price.
BOBO DONALD E JR, the CVP,Strategy/Corp Development of Edwards Lifesciences Corp, sale 5,000 shares at $71.75 during a trade that took place back on Dec 09 ’24, which means that BOBO DONALD E JR is holding 46,936 shares at $358,750 based on the most recent closing price.
Stock Fundamentals for EW
Current profitability levels for the company are sitting at:
- 0.27 for the present operating margin
- 0.78 for the gross margin
The net margin for Edwards Lifesciences Corp stands at 0.71. The total capital return value is set at 0.14. Equity return is now at value 17.93, with 13.01 for asset returns.
Based on Edwards Lifesciences Corp (EW), the company’s capital structure generated 0.06 points at debt to capital in total, while cash flow to debt ratio is standing at 1.35. The debt to equity ratio resting at 0.06. The interest coverage ratio of the stock is 57.44.
Currently, EBITDA for the company is 1.77 billion with net debt to EBITDA at -1.74. When we switch over and look at the enterprise to sales, we see a ratio of 6.61. The receivables turnover for the company is 7.24for trailing twelve months and the total asset turnover is 0.45. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.46.
Conclusion
To sum up, Edwards Lifesciences Corp (EW) has seen a better performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
